Impact of Cardiovascular Disease and Cardiac Injury on In-hospital Mortality in Patients with COVID-19: a Systematic Review and Meta-analysis

Overview

Journal Heart

Date 2020 May 29

PMID 32461330

Citations 91

Authors

Xintao Li

Bo Guan

Tong Su

Wei Liu

Mengyao Chen

Khalid Bin Waleed

Xumin Guan

Tse Gary

Zhenyan Zhu

Affiliations

Soon will be listed here.

Abstract

Background: Coronavirus disease 2019 (COVID-19) has produced a significant health burden worldwide, especially in patients with cardiovascular comorbidities. The aim of this systematic review and meta-analysis was to assess the impact of underlying cardiovascular comorbidities and acute cardiac injury on in-hospital mortality risk.

Methods: PubMed, Embase and Web of Science were searched for publications that reported the relationship of underlying cardiovascular disease (CVD), hypertension and myocardial injury with in-hospital fatal outcomes in patients with COVID-19. The ORs were extracted and pooled. Subgroup and sensitivity analyses were performed to explore the potential sources of heterogeneity.

Results: A total of 10 studies were enrolled in this meta-analysis, including eight studies for CVD, seven for hypertension and eight for acute cardiac injury. The presence of CVD and hypertension was associated with higher odds of in-hospital mortality (unadjusted OR 4.85, 95% CI 3.07 to 7.70; I=29%; unadjusted OR 3.67, 95% CI 2.31 to 5.83; I=57%, respectively). Acute cardiac injury was also associated with a higher unadjusted odds of 21.15 (95% CI 10.19 to 43.94; I=71%).

Conclusion: COVID-19 patients with underlying cardiovascular comorbidities, including CVD and hypertension, may face a greater risk of fatal outcomes. Acute cardiac injury may act as a marker of mortality risk. Given the unadjusted results of our meta-analysis, future research are warranted.

Citing Articles

Impact of Gamma COVID-19 variant on the prognosis of hospitalized pregnant and postpartum women with cardiovascular disease.

Testa C, de Godoi L, Monroy N, Bortolotto M, Rodrigues A, Francisco R Clinics (Sao Paulo). 2024; 79:100454.

PMID: 39121513 PMC: 11363992. DOI: 10.1016/j.clinsp.2024.100454.

Cardiac Injury in COVID-19: A Systematic Review of Relevant Meta-Analyses.

Kyriakoulis K, Kyriakoulis I, Trontzas I, Syrigos N, Kyprianou I, Fyta E Rev Cardiovasc Med. 2024; 23(12):404.

PMID: 39076653 PMC: 11270392. DOI: 10.31083/j.rcm2312404.

The Value of Ischemic Cardiac Biomarkers to Predict Spontaneous Breathing Trial or Extubation Failure: A Systematic Review.

Groenland C, Blijleven M, Ramzi I, Dubois E, Heunks L, Endeman H J Clin Med. 2024; 13(11).

PMID: 38892952 PMC: 11173145. DOI: 10.3390/jcm13113242.

Determinants of mortality in hypertensive patients admitted with COVID-19: a single-centre retrospective study at a tertiary hospital in South Africa.

Ikram A, Pillay S BMC Cardiovasc Disord. 2024; 24(1):298.

PMID: 38858632 PMC: 11163696. DOI: 10.1186/s12872-024-03964-2.

Acute Myocardial Infarction in COVID-19 Patients-A Review of Literature Data and Two-Case Report Series.

Nechita L, Niculet E, Baroiu L, Balta A, Nechita A, Voinescu D J Clin Med. 2024; 13(10).

PMID: 38792477 PMC: 11121956. DOI: 10.3390/jcm13102936.

References

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L . Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5):531-538. PMC: 7087935. DOI: 10.1007/s00392-020-01626-9. View

Corrales-Medina V, Madjid M, Musher D . Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis. 2010; 10(2):83-92. DOI: 10.1016/S1473-3099(09)70331-7. View

Han Y, Zeng H, Jiang H, Yang Y, Yuan Z, Cheng X . CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic. Circulation. 2020; 141(20):e810-e816. DOI: 10.1161/CIRCULATIONAHA.120.047011. View

Ruan Q, Yang K, Wang W, Jiang L, Song J . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846-848. PMC: 7080116. DOI: 10.1007/s00134-020-05991-x. View

Driggin E, Madhavan M, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G . Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020; 75(18):2352-2371. PMC: 7198856. DOI: 10.1016/j.jacc.2020.03.031. View

10.

Yuan M, Yin W, Tao Z, Tan W, Hu Y . Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020; 15(3):e0230548. PMC: 7082074. DOI: 10.1371/journal.pone.0230548. View

11.

Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-12. DOI: 10.1001/jama.283.15.2008. View

12.

. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2):145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003. View

13.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q . Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94:91-95. PMC: 7194638. DOI: 10.1016/j.ijid.2020.03.017. View

14.

Yang C, Jin Z . An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases. JAMA Cardiol. 2020; 5(7):743-744. DOI: 10.1001/jamacardio.2020.0934. View

15.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5):475-481. PMC: 7102538. DOI: 10.1016/S2213-2600(20)30079-5. View

16.

Zeng J, Huang J, Pan L . How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital. Intensive Care Med. 2020; 46(6):1111-1113. PMC: 7079823. DOI: 10.1007/s00134-020-05993-9. View

17.

Lippi G, Lavie C, Sanchis-Gomar F . Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020; 63(3):390-391. PMC: 7127395. DOI: 10.1016/j.pcad.2020.03.001. View

18.

Xiong T, Redwood S, Prendergast B, Chen M . Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020; 41(19):1798-1800. PMC: 7454513. DOI: 10.1093/eurheartj/ehaa231. View

19.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

20.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View